Which of the following statements about Diazoxide is false ?
**Core Concept:** Diazoxide is an oral antihypertensive drug used in the treatment of various conditions, including hypertension, diabetes insipidus, and certain types of diabetes mellitus. It works by stimulating the pancreatic beta cells to secrete insulin and inhibiting glucagon secretion, thus lowering blood glucose levels.
**Why the Correct Answer is Right:** Diazoxide works as a potassium channel opener, specifically activating ATP-sensitive potassium (KATP) channels in pancreatic beta cells. This leads to membrane hyperpolarization, reduced intracellular calcium concentration, and insulin release. Diazoxide does not affect alpha cells or other cell types, making it selective for beta cells.
**Why Each Wrong Option is Incorrect:**
A. This statement is correct, as Diazoxide has a selective effect on pancreatic beta cells.
B. This option is incorrect because Diazoxide primarily targets pancreatic beta cells and does not affect alpha cells or other cell types.
C. This statement is correct, as Diazoxide is an oral antihypertensive drug used in specific conditions mentioned.
D. This option is incorrect because the mechanism of action described (glucagon secretion inhibition) corresponds to the primary action of Diazoxide on pancreatic alpha cells, not its main effect on beta cells.
**Clinical Pearl:** The correct use of Diazoxide requires careful monitoring of blood glucose levels and electrolytes, as it may cause hypoglycemia and hypokalemia. Inappropriate administration may lead to severe hypoglycemia and electrolyte imbalances in patients with underlying diabetes insipidus or other conditions requiring Diazoxide treatment.
**Correct Answer:** D. Inhibiting glucagon secretion is the primary action of Diazoxide, which corresponds to its effect on alpha cells (not beta cells).